Ensuring Patient Access to Critical Breakthrough Products Act
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.· September 17, 2025
The summary
What this bill does
Summary not yet available for this bill.
Legislative timeline
From introduction
Sep 15, 2025
Introduced & referred to committee
Congressional support
Sponsors & Cosponsors
Member of Congress · R-UT
45 cosponsors
U.S. Representative - WA District 1 · D-WA
U.S. Representative - IN District 2 · R-IN
U.S. Representative - AL District 7 · D-AL
U.S. Representative - FL District 12 · R-FL
U.S. Representative - MA District 3 · D-MA
U.S. Representative - NY District 24 · R-NY
U.S. Representative - MN District 7 · R-MN
U.S. Representative - IL District 10 · D-IL
Member of Congress · D-CA
Member of Congress · R-GA
U.S. Representative - MA District 4 · D-MA
U.S. Representative - WV District 1 · R-WV
+ 33 more cosponsors
Roll-call vote
The vote, by member
The vote, by member
VERSION CHANGES
What changed,
and where.
Loading the bill text comparison.
Bill Metadata
| Congress | 119 |
| Bill Type | HR |
| Bill Number | 5343 |
| Origin Chamber | House |
| Current Status | Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3. |
| Policy Area | Health |
| Primary Committee | Not assigned |
| Introduced | September 15, 2025 |
| Latest Action | September 17, 2025 |
| Cosponsors | 45 · House vote — · 1 views |